Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE ( © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 May 2021

Abstract and Keywords

Intermittent explosive disorder (IED), a DSM-IV-TR disorder characterized by significant acts of aggression and violence, is being increasingly recognized as a prevalent and chronic disorder. Given the personal, social, and economic costs associated with IED, there is a clear need for well-validated assessment measures and efficacious treatments. However, there are currently no published, well-validated diagnostic measures of IED. With regard to treatment, preliminary evidence from a few randomized clinical trials suggests that selective serotonin reuptake inhibitors and cognitive behavioral psychotherapy may be effective in treating IED. However, more research is needed before either can be considered an empirically supported treatment for IED. In this chapter, we discuss (1) challenges in developing reliable and valid assessments for IED and (2) issues relevant to developing and testing psychological and pharmacological treatment interventions for IED.

Keywords: intermittent explosive disorder, aggression, assessment, psychotherapy, pharmacotherapy, selective serotonin reuptake inhibitor (SSRI), cognitive behavioral therapy

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.